Akèy › Timè karsinoyid
Etid klinik pou Timè karsinoyid ap rekrite nan Etazini
7 etid pou Timè karsinoyid ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
- Florid3 etid
- Iowa3 etid
- Kalifòni3 etid
- Kentucky3 etid
- Maryland3 etid
- Ohio3 etid
- Pennsylvania3 etid
- Utah3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Natural History of Familial Carcinoid Tumor
Ap rekriteEtid obsèvasyon
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT00646022Lu-177-DOTATATE (Lutathera) in Combination With Olaparib in Inoperable Gastroenteropancreatico Neuroendocrine Tumors (GEP-NET)
Ap rekriteFaz 1/2
Laj 18 a 100 · Tout sèks · Mizajou Sep 28, 2026 · NCT04086485Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07165132Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07087054Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 28, 2026 · NCT05263050Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT05477576Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Ap rekrite
Laj 18 a 99 · Tout sèks · Mizajou Feb 20, 2026 · NCT04907643Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.